Altus completes Phase I study of recombinant human growth hormone - TradingMarkets.com

by Hgh @ Mon, 19 Jan 2009 03:00:02 -0500
ALTU-238 is being developed as a subcutaneously administered, long acting formulation of recombinant human growth hormone that employs Altus's proprietary protein crystallization and formulation technology, for patients with growth hormone ...
  • Recent posts: